Delivery Order SPE2DB20D1051-SPE2DB25FD8TN
- Not listed
- Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, has been awarded a firm fixed price delivery order valued at two hundred thirty-three dollars and ninety-six cents ($233.96) by the Defense Logistics Agency Troop Support Medical to supply twenty-four (24) packets of 5% Imiquimod cream. Performance will take place in Conshohocken, Pennsylvania under a July 7-10, 2023 period of performance. The Defense Logistics Agency Troop Support Medical utilizes contracts to...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,306.88 to AmerisourceBergen Drug Corp for Imiquimod 3.75% cream (28-count units) on August 7, 2025, with an ultimate completion date of August 8, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider...
- The Defense Logistics Agency awarded a delivery order valued at $2,133.86 to AmerisourceBergen Drug Corp for the supply of Imiquimod 3.75% cream (28 units) on August 7, 2025, with completion scheduled for August 8, 2025. This firm fixed price contract was competitively awarded with no set-aside designation and is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of Imiquimod 5% Cream Packets. The order has a ceiling value of $10,479.63 and is a firm fixed-price contract. The contract has an ultimate completion date of August 14, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded multiple federal contracts and indefinite delivery contracts (IDCs) by the DLA and other agencies to provide a wide range of medical...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Imiquimod 3.75% cream (28 count) with a ceiling value of $1,628.06 under a firm fixed price contract type. The award was made on September 2, 2025, with an ultimate completion date of September 3, 2025, and was not designated as a set-aside contract. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the delivery order at its...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $1,274.31 on August 21, 2025, with an ultimate completion date of August 22, 2025. The order is for Imiquimod 3.75% cream in 28-count units, a topical immunomodulatory medication used primarily for treating certain skin conditions. This non-set-aside, firm fixed price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical,...
- This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is for the delivery of Imiquimod 5% Cream Packets 24s. The contract, valued at $1,726.61, is a Firm Fixed Price Delivery Order awarded by the Defense Logistics Agency (DLA), a defense agency. The contract has an ultimate completion date of January 15, 2025 and was awarded on January 14, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite...
- This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the delivery of Imiquimod 3.75% Cream in 28-count packages. The contract has a potential value of $1,187.69 and a completion date of February 8, 2024. AmerisourceBergen Drug Corp is the sole prime contractor on this delivery order, which does not have a set-aside designation. The company also...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a firm fixed price delivery order contract worth $1,724.56 from the Defense Logistics Agency (DLA) Troop Support Medical to supply IMIQUIMOD 5% CR 24S, a pharmaceutical product. The contract has a completion date of February 22, 2024 and was awarded on January 25, 2024. This delivery order is placed under an indefinite delivery contract (IDC) that Amerisourcebergen holds with DLA, valued at up to...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Imiquimod 3.75% Cream Pump, 7.5 gm. The $3,193.43 firm fixed-price contract has an ultimate completion date of April 18, 2024. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, particularly the Department of Defense (DoD) and Veterans Affairs (VA)...
- SPE2DB20D1051Indefinite Delivery Contract
- SPE2DB20D1051-SPE2DB25FD8TNDelivery Order
AmerisourceBergen Drug Corp was awarded a delivery order valued at $3,325.66 by the Defense Logistics Agency (DLA) on July 14, 2025, for the supply of Imiquimod 5% Cream in packets of 24 units. This is a firm fixed-price delivery order with an ultimate completion date of July 15, 2025, and represents a non-set-aside competitive award. The order will be fulfilled from AmerisourceBergen's Conshohocken, Pennsylvania facility, where the company maintains its corporate headquarters. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical support vehicle valued at $999.99 million and extending through December 2026. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company's DLA IDC serves as a global pharmaceutical support vehicle enabling delivery of an extensive range of pharmaceutical products, medical supplies, brand-name and generic medications, vaccines, and specialized medical commodities across multiple therapeutic domains to support Defense Health Agency operations and other federal healthcare systems. This individual delivery order for topical pharmaceutical product represents one component of AmerisourceBergen's substantial federal contract portfolio demonstrating the company's capability to meet diverse and specialized federal medical supply requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.3k | 7/14/25 |